Follow The Filings

HSTM Healthstream Inc.

Health Care, filed as HEALTHSTREAM INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $16M
  • 1 add

In 2026 Q2 First Eagle Investment Management added to Healthstream.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (First Eagle Investment Management). Not free-float ownership.

  1. First Eagle Investment Manage... Add 0.03%

Who owns HSTM

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.03%, was 0.02% Add +39.0% 591,898 $16M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by HSTM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HSTM insider trades
  • None no insider bought on the open market
  • $4.5M sold by 4 insiders outside a trading plan
  • $274K sold by 1 insider under 10b5-1 plans
  1. Robert A Frist Jr. CEO
    Sale
    $4.3M 144,068 shares at $29.50 3.6% of stake
    Traded Sep 14 Filed Sep 15
    ↗
  2. Linda Rebrovick Director
    Planned sale
    $174K 6,000 shares at $29.00 11% of stake
    Traded Jul 6 Filed Jul 7
    ↗
  3. Linda Rebrovick Director
    Planned sale
    $50K 2,000 shares at $25.00 3.6% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  4. Linda Rebrovick Director
    Planned sale
    $50K 2,000 shares at $25.00 3.4% of stake
    Traded May 28 Filed Jun 1
    ↗
  5. Kevin P O'Hara Executive Vice President
    Sale
    $72K 3,000 shares at $24.08 13% of stake
    Traded May 20 Filed May 20
    ↗
  6. Jeff Cunningham Chief Technology Officer
    Sale
    $51K 2,100 shares at $24.09 6.3% of stake
    Traded Dec 10, 2025 Filed Dec 10, 2025
    ↗
  7. Kevin P O'Hara Executive Vice President
    Sale
    $49K 2,000 shares at $24.26 11% of stake
    Traded Dec 8, 2025 Filed Dec 8, 2025
    ↗
  8. Tate Deborah Taylor Director
    Sale
    $40K 1,580 shares at $25.46 6.4% of stake
    Traded Nov 26, 2025 Filed Dec 1, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 37 option exercises, 30 share withholdings for taxes, 5 gifts, 2 stock grants, and 1 sale back to the company.

SEC filings

Recent issuer filings from EDGAR, 8 shown.

Filed Form Detail Links
8-K 5.02 Filing Doc
SCHEDULE 13D — Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $279.06M $291.65M $304.06M
Net income $15.21M $20.01M $18.34M
Net margin * 5.5% 6.9% 6.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $130.21M $153.12M $119.66M
Total non-current assets * $369.73M $357.64M $400.72M
Total assets $499.94M $510.77M $520.37M
Total current liabilities $118.36M $115.69M $124.15M
Total equity $340.75M $359.36M $354.02M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $63.97M $57.66M $63.32M
Cash from investing -$56.6M -$33.97M -$50.35M
Cash from financing -$13.04M -$4.52M -$36.27M
Net change in cash -$5.69M $19.14M -$23.31M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.